SARS CoV-2: Rising to the testing challenge in the United States
Limited SARS-CoV-2 testing and resource availability continues to be a challenge for the lab medicine community. Join Dr. Steven Cagas and Dr. M. Laura Parnas as they provide an overview of the CoV family of viruses, the unique features of SARS-CoV-2 and COVID-19, and the current outbreak epidemiology.
The Role of Laboratory Diagnostics in SARS-CoV-2 Infection and Related Comorbidities: Experiences and Population Management Strategies from Highly Affected Regions of China and Italy
Laboratory tests are vital throughout many clinical pathways. There are at least three major areas where in vitro diagnostics can provide essential contributions to diagnose and manage care of patients with suspected or confirmed SARS-CoV-2 infection. Join Professor Mario Plebani and Professor Shu Kui Wang to learn how laboratory medicine could efficiently contribute to counteract the COVID-19 outbreak.
Clinical Application of High-Sensitivity Cardiac Troponin Testing in the Emergency Setting
A paradigm shift has occurred with the advent of high-sensitivity cardiac troponin (hs-cTn) testing; whereby a low, measurable normal cardiac troponin concentration provides important information—something that was not possible with previous versions of the test due to the higher analytical sensitivity of the non-hs-cTn assays. This lecture will review key analytical and clinical aspects when using hs-cTn assays in the emergency setting.
Curbing the Opioid Crisis: The Role of the Clinical Laboratory for Pain Management
Drug overdose is now the leading cause of accidental death in the United States. In this webinar, you will learn why your clinical laboratory is critically important in helping clinicians care for patients struggling with drug abuse. You will also learn about the advantages of using a specific urine drug screening technology that eliminates cross-reactivities with other drugs.
The Role of Procalcitonin (PCT) and other Biomarkers to aid in the Differential Diagnosis and Management of Bacterial Infectious Diseases
Biomarkers such as procalcitonin (PCT) can further guide prognosis of bacterial sepsis, assessment of mortality risk, and duration of antibiotic therapy. Join Stefan Riedel, MD, PhD, as he shares his working knowledge of the utility of procalcitonin and other biomarkers in diagnosing and managing sepsis and other bacterial infections, such as bacterial pneumonia.
See the full listing of Free Lab Medicine Webinars >>